How Long Does Semaglutide Last After Opening at the Bench

How long semaglutide lasts after opening, and what counts as "opened"

A factory-sealed, FDA-approved semaglutide pen is rated to last up to 56 days after its first use, stored at room temperature (15°C to 30°C) or in a refrigerator (2°C to 8°C), according to its FDA-approved product label. Semaglutide is a GLP-1 receptor agonist: a peptide (a chain of amino acids) designed to mimic a natural signaling molecule. It is supplied as a ready-to-use liquid solution in the pen format described in that label.

"Opened" means the moment the seal is first punctured or the cap is first removed for use. That is the day the clock starts, not the manufacture date printed on the box.

That 56-day figure is specific to one commercial, pre-mixed, preserved product that went through formal stability testing before approval. It does not describe every semaglutide sample, and it says nothing about a peptide a researcher reconstitutes from freeze-dried (lyophilized) powder at the bench using a different diluent.

How opened GLP-1 injectable products compare on paper

Two related GLP-1 peptides have public FDA label data on post-opening storage: semaglutide and tirzepatide (a related but chemically distinct GLP-1 peptide found in a different product). Lining up their labeled numbers shows how much the storage window depends on the exact product format, not just the peptide class.

None of these windows are interchangeable across products.

Why a reconstituted peptide sample isn't the same as a sealed pen

A 2024 review in Pharmaceutical Research on the stability of protein pharmaceuticals describes two broad ways a protein or peptide can degrade in liquid form: chemical degradation, where bonds in the molecule break or change, and physical degradation, where the molecule unfolds or clumps without any bonds breaking. Which one dominates, and how fast, depends heavily on the exact formulation: the water, the preservatives, the stabilizers, and the concentration used.

That is the core reason a factory label number cannot be copied onto a bench-reconstituted vial. The commercial pen's 56-day figure reflects testing on one exact pre-mixed formulation. Swap in a different diluent, a different peptide concentration, or a different container, and the chemistry is no longer the same system.

Diluent choice matters directly here. Sterile water for injection, per its own FDA label, contains no bacteriostat (preservative) or antimicrobial agent and is supplied only in single-dose containers meant for one use. Bacteriostatic water carries an added preservative instead, which is what allows it to be drawn from more than once. Using plain sterile water as if it were a multi-use diluent skips the one safeguard that preservative is there to provide.

What researchers get wrong about semaglutide shelf life after opening

• Assuming the 56-day pen figure applies to any semaglutide sample. It describes one specific, factory-sealed, preserved commercial formulation tested for that exact shelf life, not a self-reconstituted vial made with a different diluent.
• Thinking refrigeration cancels out the contamination clock. The FDA's alert on compounded GLP-1 drugs recommends discarding a multi-dose vial within 28 days of first use, even if solution remains, regardless of storage temperature.
• Reusing the same needle or syringe for repeated draws from one vial. The same FDA alert specifically names needle and syringe reuse as a contamination risk for multi-dose GLP-1 vials.
• Skipping the visual check before drawing a sample. The semaglutide pen label specifies the solution should be clear and colorless, and should not be used if particulate matter or discoloration is visible.
• Freezing a sample to "pause" its shelf life. Both the semaglutide and tirzepatide labels state the product must never be frozen, and must be discarded if it has been frozen.

A practical way to date, diluent, and log your reconstituted samples

Write the first-puncture date on the vial or cartridge the moment you open or reconstitute it. That date, not the kit's print date or the powder's original date, is what any shelf-life window counts from.

If you have no stability data for your exact formulation, the FDA's general guidance for multi-dose sterile preparations is a reasonable default ceiling to log against: discard within 28 days of first use, even if volume remains, because contamination risk rises after that point.

Match the diluent to how many times you'll draw from the vial. Bacteriostatic water, which contains a preservative (0.9% benzyl alcohol in the Pfizer Hospira USP 30 ml multi-dose vial PreppinPeppers carries), is built for repeated draws. Plain sterile water is a single-dose product by its own FDA label and isn't designed to be reopened.

Loading each reconstituted batch into its own labeled 3 ml cartridge, like the clear or amber cartridges PreppinPeppers sells for its reusable pens such as the V1 Peptide Pen, keeps batches physically separated. If one cartridge shows a problem, such as cloudiness or discoloration, you discard that one sample instead of a shared vial feeding several projects.

Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators

Sources

Correction (2026-10-03): an earlier version said a multi-dose vial carries a shorter cutoff than a single-dose pen, and asked why in the FAQ. The labels say otherwise: the tirzepatide multi-dose vial allows 30 days after first use against 21 days unrefrigerated for its single-dose pen or vial. We removed that sentence and FAQ, and renamed the table column from 'Window after first use' to 'Labeled storage window', because the single-dose rows give storage limits, not windows after first use.

Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.